Danish biotech Orbis secures $94m to develop oral versions of biologics
The Series A funding round was led by New Enterprise Associates (NEA) with participation from new investors, including Eli Lilly.
The Series A funding round was led by New Enterprise Associates (NEA) with participation from new investors, including Eli Lilly.
Eli Lilly’s investment is seen as an opportunity to drive economic growth for the UK while improving public health.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
Novo Nordisk invests $1.2bn in new Denmark facility
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
Vifor Pharma offers £23m to NHS to resolve CMA investigation